Skip to content
Lower risk Drug recall · FDA · Published February 9, 2024

HydrALAZINE 10mg Tablets Recall: Remote Risk of Temporary Health Effects

Major Pharmaceuticals recalls HydrALAZINE Hydrochloride 10mg tablets (Lot T04680) due to a remote possibility of temporary health effects from impurities. No immediate action needed as the risk is low.

🇺🇸 FDA recall #D-0324-2024DrugMajor Pharmaceuticals ›
Take action

Contact the company

Recalling firmThe Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories341 Mason Rd · La Vergne, TN 37086-3606
✎ GovInfoNow plain-language explainer

Major Pharmaceuticals is recalling HydrALAZINE Hydrochloride 10mg tablets (Lot T04680) because routine testing found impurities that could cause temporary health issues. This risk is very low and not urgent. Read more at govinfonow.com/recall/32824-hydralazine-10mg-tablets-recall-remote-risk-of-temporary-health-effects.

Source Summary by GovInfoNow · govinfonow.com/recall/32824-hydralazine-10mg-tablets-recall-remote-risk-of-temporary-health-effects · Updated August 18, 2026 · FDA enforcement record: FDA #D-0324-2024

Cite this page

“HydrALAZINE 10mg Tablets Recall: Remote Risk of Temporary Health Effects.” GovInfoNow, updated August 18, 2026. https://govinfonow.com/recall/32824-hydralazine-10mg-tablets-recall-remote-risk-of-temporary-health-effects. Based on FDA recall #D-0324-2024 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0324-2024%22&limit=1).

The FDA announced on Feb. 9, 2024, that Major Pharmaceuticals is recalling HydrALAZINE Hydrochloride Tablets, USP 10mg due to out-of-specification impurities. The agency classified the recall as Class II.

How to tell if you have it

  • Brand: Major Pharmaceuticals
  • Product: HydrALAZINE Hydrochloride Tablets, USP 10mg
  • Packaging: 100-count (10x10 blister cards)
  • Lot code: T04680
  • NDC: 0904-6440-61
  • Expiration date: 6/2024

The hazard

The recall stems from an out-of-specification result obtained during routine stability testing for impurities. The FDA stated there is a remote possibility that use of this product could cause medically reversible or transient adverse health consequences.

Context

GovInfoNow's records show Major Pharmaceuticals has 14 other recalls on record since May 31, 2023. Recent brand recalls include a Sept. 12, 2025, recall of Major Chlorpromazine 50mg Tablets for N-Nitroso Desmethyl Chlorpromazine risk and a Sept. 2, 2025, recall of Major Pharmaceuticals Sulfamethoxazole-Trimethoprim for foreign microorganism risk. Other recent recalls of similar products include Macleods Olanzapine Tablets 5mg Recall (Aug. 27, 2026), Ajanta Pharma Fluphenazine Tablets Recall (Aug. 25, 2026), and Hikma Ramipril Capsules 10mg Recall (Aug. 24, 2026).

How to tell if you have this one

Check for HydrALAZINE Hydrochloride 10mg tablets in 100-count blister packs with Lot Number T04680. The product is prescription-only and distributed by Major Pharmaceuticals.

  • Brand
    Major Pharmaceuticals
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Check Product Details

    Look for the lot number T04680 on the blister pack to confirm if your tablets are affected.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “The product was distributed nationwide within the United States.” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA terminated this recall 22 months after the firm started it.

1. Firm started the recall: Feb 9, 202412. FDA classified it Class II: Feb 13, 202423. Published in FDA’s Enforcement Report: Feb 21, 202434. FDA terminated the recall: Dec 22, 2025420242025
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

✎ GovInfoNow

Questions people ask

Could this cause serious injury?

The recall states a remote possibility of temporary health effects, not serious injury. This is a low-risk situation.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0324-2024 (February 9, 2024) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0324-2024 to see it in context.
  • Plain-language summary written by qwen3:4b on August 18, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA